PCSK9 and cardiovascular disorder: This work provides valuable insights into the design of small-molecule inhibitors targeting PCSK9, establishing a foundation for subsequent experimental validation and optimization of these compounds for the treatment of hyperlipidemia and related cardiovascular diseases.